Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

By Scott D. Ramsey, R. Willke, A. Briggs, Ruth E. Brown, M. Buxton, A. Chawla, J. Cook, Henry A. Glick, B. Liljas, D. Petitti and 1 more. Value in Health, 2005

728 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013, positive): “The CHEERS statement attempts to consolidate and update previous efforts [9-20] into a single useful reporting guidance.”
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (2013, neutral): “[16] Ramsey S, Willke R, Briggs A, et al.”
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. (2007, methodology): “The Task Force reviewed other ISPOR guidance documents that were developed to inform good scientific conduct [37, 38 ] and National Guidelines for BIAs [7‐16].”
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. (2014, background): “In the development of health interventions, early consideration of resource use has become essential, as increasing health care costs present challenges for even the richest nations [27].”
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. (2015, methodology): “Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force report in 2005 [5].”